"Cancer disease progression" trang 1 - tải miễn phí từ tailieunhanh
Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial
7    73    1
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer

Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
9    55    1
Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation

Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation
15    56    3
Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status

Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status
7    49    1
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
10    5    1
High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer

High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
9    58    0
A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping

A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping
11    50    1
Variable selection for disease progression models: Methods for oncogenetic trees and application to cancer and HIV

Variable selection for disease progression models: Methods for oncogenetic trees and application to cancer and HIV
16    60    1
Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: A subanalysis from a phase 3 trial (MPACT)

Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: A subanalysis from a phase 3 trial (MPACT)
10    64    1
Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgensignaling-targeted inhibitor resistance

Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgensignaling-targeted inhibitor resistance
8    54    1
Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles

Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles
11    53    1
Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC

Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC
9    7    1
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential

A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential
10    63    0
Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer

Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer
10    40    1
Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer
14    75    1
CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor

CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor
10    50    1
A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease

A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease
11    79    1
Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer

Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer
8    94    0
Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease

Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease
10    76    0
Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance

Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance
11    81    1